From Pilot to Production: Navigating AI Adoption Through Risk-First Prioritization

About the Guide: 

As the adoption of large language models (LLMs) accelerates across nearly every industry, Life Sciences organizations are increasingly exploring how to integrate these technologies into their operations. Generative AI holds immense promise, ranging from reducing human error to significantly lowering operational costs. Yet, despite this potential, the Life Sciences sector remains notably cautious² when it comes to technology adoption, particularly due to its high regulatory burden and low risk tolerance.

RCH Returns to Bio-IT World Expo & Conference 2025